Delivery Order SPE2DB22D9130-SPE2DB25FE0DP

Award Date 4/8/25
Potential Completion Date 4/29/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This is a firm fixed-price delivery order contract valued at $7,104.00, with a period of performance through May 20, 2024. The contract is not associated with a set-aside program. DMS Pharmaceutical Group holds a larger...
This federal contract award is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $28,176.50 and has an ultimate completion date of June 29, 2022. This award is not associated with any set-aside designation. DMS...
This federal contract award is for the delivery of MIRENA 52 MG SYSTEMS, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,041.56 and an ultimate completion date of March 11, 2025. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The total ceiling value of the contract is $11,840.00, and it is structured as a firm fixed-price delivery order with no set-aside designation. The contract has an ultimate completion date of August 28, 2024. DMS...
This federal contract award is for the delivery of MIRENA 52 MG SYSTEMS, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $15,623.10 and an ultimate completion date of April 21, 2025. This contract is not associated with a set-aside designation....
This federal contract award is for the delivery of Mirena 52 mg systems, a contraceptive implant, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,184 and a period of performance through July 3, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999...
This federal contract award is for the delivery of Mirena 52 mg Systems, a type of intrauterine device, to the Defense Logistics Agency (DLA). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order type, with a ceiling value of $4,736.00 and an ultimate completion date of December 26, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $59,200.00 and an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group Inc. specializes in providing a wide range of pharmaceutical...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The $2,603.85 firm fixed-price delivery order contract was awarded on March 13, 2025 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an ultimate completion date of April 3, 2025 and is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $7,104.00 and an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with...
  • SPE2DB22D9130
    Indefinite Delivery Contract
  • SPE2DB22D9130-SPE2DB25FE0DP
    Delivery Order

This federal contract award is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order type, a ceiling value of $3,124.68, and an ultimate completion date of April 29, 2025. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

Generated 7/8/25, 2:20 PM